Our laboratory findings revealed that diabetic COVID-19 patients also had high levels of inflammatory biomarkers including CRP, ferritin, and D-dimer, neutrophilic leukocytosis, and lymphopenia, corroborating with studies reported in the literature [25,26]. The gene discussed is CRP; the disease is lymphopenia.